Inventiva Ownership | Who Owns Inventiva?
Inventiva Ownership Summary
Inventiva is owned by 45.31% institutional investors, and 54.69% retail investors. Samsara biocapital is the largest institutional shareholder, holding 0.82% of IVA shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 0.82% of its assets in Inventiva shares.
IVA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Inventiva | 45.31% | - | 54.69% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Samsara biocapital | 5.19M | 0.82% | $28.83M |
| Caligan partners lp | 4.97M | 0.78% | $27.61M |
| Paradigm biocapital advisors lp | 4.00M | 0.63% | $22.20M |
| Millennium management | 2.99M | 0.47% | $16.58M |
| Franklin resources | 2.46M | 0.39% | $13.66M |
| Ubs group | 2.32M | 0.36% | $12.87M |
| Polar capital | 2.13M | 0.33% | $11.83M |
| Andera partners | 1.82M | 0.29% | $10.09M |
| Boothbay fund management | 1.47M | 0.23% | $8.16M |
| Nea management company | 1.46M | 0.23% | $8.03M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Andera partners | 1.82M | 5.70% | $10.09M |
| Samsara biocapital | 5.19M | 2.80% | $28.83M |
| Propel bio management | 724.68K | 2.52% | $3.99M |
| Caligan partners lp | 4.97M | 1.84% | $27.61M |
| Highvista strategies | 615.67K | 0.94% | $3.42M |
| Ikarian capital | 1.43M | 0.64% | $7.84M |
| Nea management company | 1.46M | 0.46% | $8.03M |
| Paradigm biocapital advisors lp | 4.00M | 0.45% | $22.20M |
| Diadema partners lp | 352.40K | 0.33% | $1.94M |
| Persistent asset partners | 128.10K | 0.27% | $710.95K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Caligan partners lp | 4.97M | 1.84% | 2.97M |
| Point72 asset management | 956.22K | 0.01% | 956.22K |
| Ikarian capital | 1.43M | 0.64% | 926.50K |
| Boothbay fund management | 1.47M | 0.11% | 811.44K |
| Deep track capital, lp | 1.22M | 0.11% | 732.45K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | - | - | -1.30M |
| Alyeska investment group | - | - | -500.00K |
| Stempoint capital lp | - | - | -467.24K |
| J. goldman & co lp | 103.52K | 0.02% | -412.93K |
| Ubs group | 2.32M | 0.00% | -325.01K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 956.22K | 0.01% | 956.22K | $5.31M |
| Highvista strategies | 615.67K | 0.94% | 615.67K | $3.42M |
| Integral health asset management | 400.00K | 0.11% | 400.00K | $2.22M |
| Artisan partners limited partnership | 323.01K | 0.00% | 323.01K | $1.79M |
| Hudson bay capital management lp | 145.46K | 0.00% | 145.46K | $807.30K |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -1.00 |
| Western wealth management | -5.00 |
| Bnp paribas arbitrage, snc | -100.00 |
| Eversource wealth advisors | -604.00 |
| Jones financial companies lllp | -881.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 88 | 33.33% | 84,640,508 | 61.64% | 45 | 67.08% | 67 | 52.27% | 7 | -30.00% |
| Mar 31, 2026 | 61 | 15.09% | 47,922,564 | 2.59% | 7 | 0.41% | 43 | -2.27% | 8 | 700.00% |
| Dec 31, 2025 | 10 | -33.33% | 6,959,352 | 36.28% | 6 | 6.63% | 7 | -12.50% | - | -100.00% |
| Sep 30, 2025 | 5 | -58.33% | 91,479 | -98.14% | - | 0.20% | 3 | -50.00% | - | -100.00% |
| Jun 30, 2025 | 12 | 50.00% | 4,928,159 | 1.39% | 9 | 10.84% | 6 | 200.00% | 2 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 1.93M | 0.82% | 256.24K |
| abrdn World Healthcare | 1.38M | 0.58% | 166.60K |
| abrdn Life Sciences Investors | 1.25M | 0.53% | 160.40K |
| Franklin Biotechnology Discovery A | 1.04M | 0.44% | 72.96K |
| Polar Capital Biotech S Inc | 976.21K | 0.41% | -943.34K |
| Fidelity Advisor Biotechnology I | 685.40K | 0.29% | - |
| Simplify Propel Opportunities ETF | 313.48K | 0.13% | - |
| Artisan International Small-Mid Investor | 144.29K | 0.06% | -51.45K |
| Artisan Non-U.S. Small-Mid Growth Comp | 144.29K | 0.06% | -51.45K |
| Russell Inv Tax-Managed US Mid&Sm Cap S | 67.80K | 0.03% | - |
IVA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools